Date & Time
March 7 – 8, 2025
The scientific programm is scheduled to start on Friday at 13:00 and end on Saturday at 13:30.
Venue
HYATT REGENCY SOFIA
Vasil Levski Square | Sofia 1504 | Bulgaria
Contact
Please contact us at cecog@wma.co.at for any questions related to the meeting.
Programme
Colorectal cancer is the third most common cancer in men and the second most common cancer in women worldwide. Many factors may be responsible for the development of this disease, including genetic and environmental factors.
The CECOG Colon Cancer Academy is an academic symposium, which is supervised by an independent scientific committee of international highly recognized experts in the field:
Christoph Zielinski (Vienna, Austria)
Christiane Thallinger (Vienna, Austria)
Rosi Krasteva (Sofia, Bulgaria)
Assen Dudov (Sofia, Bulgaria)
The meeting is intended and has provided a platform for international multidisciplinary exchange. Moreover, and foremost, the CECOG Colon Cancer Academy is intended to present newest advances in the treatment of colon cancer. Participants of the CECOG Colon Cancer Academy will be exposed to an extremely stimulating and interactive environment (highly respected international scientists, medical oncologists, surgeons, pathologists, radiologists, radiotherapists and basic scientists), enabling the exchange of ideas, and fostering partnerships.
The CECOG Colon Cancer Academy will feature the latest research from leading experts and will help build collaborations to advance the prevention, detection, and treatment of colon cancer. The Academy will also shed light on future aspects of care and treatment.
Programme
All times are in local Sofia, Bulgaria time – Eastern European Time
March 7, 2025
| Start | End | Session / Presentation |
|---|---|---|
| 13:00 | 13:50 | Welcome & Special Lectures |
| Chair | R. Krasteva, Sofia | |
| Chair | C. Zielinski, Vienna | |
| 13:00 | 13:05 | Welcome on behalf of CECOG |
| Speaker | C. Zielinski, Vienna | |
| 13:05 | 13:10 | Welcome addresses by local hosts |
| Speaker | R. Krasteva, Sofia | |
| 13:10 | 13:30 | What are the subgroups of CRC defined by molecular testing? |
| Speaker | L. Brcic, Graz | |
| 13:30 | 13:50 | Colon Cancer: Responding to Patients’ Needs |
| Speaker | A. Cardone, San Miniato | |
| 13:50 | 14:00 | Coffee Break |
| 14:00 | 15:10 | Resectable CRC |
| Chair | C. Thallinger, Vienna | |
| Chair | A. Sartore-Bianchi, Milan | |
| 14:00 | 14:20 | Minimal Invasive Surgery vs Extensive Surgery |
| Speaker | H.Rosen, Vienna | |
| 14:20 | 14:40 | Defining the place of systemic therapy in nonmetastatic CRC: Selection of patients, compounds and duration of treatment |
| Speaker | A. Sartore-Bianchi, Milan | |
| 14:40 | 15:00 | Personalized treatment of advanced CRC |
| Speaker | M. Petrova, Sofia | |
| 15:00 | 15:10 | Q&A |
| 15:10 | 15:40 | Coffee Break |
| 15:40 | 17:50 | Advanced CRC, First Line Treatment |
| Chair | C. Zielinski, Vienna | |
| Chair | R. Krasteva, Sofia | |
| 15:40 | 16:00 | First line treatment of advanced CRC: Which chemotherapy regimen, which antibody and why? |
| Speaker | D. Arnold, Hamburg | |
| 16:00 | 16:20 | Treatment of RAS wild-type metastatic colorectal cancer: the past, the present, the future (Online) |
| Speaker | F. Ciardiello, Naples | |
| 16:20 | 16:40 | Second line treatment and beyond |
| Speaker | G. Prager, Vienna | |
| 16:40 | 17:00 | Treatment in KRAS mutated CRCs |
| Speaker | D. Arnold, Hamburg | |
| 17:00 | 17:10 | Coffee Break |
| 17:10 | 17:30 | The place of minimal invasive interventions in advanced CRC: Methods, options and outcomes |
| Speaker | M. Funovics, Vienna | |
| 17:30 | 17:50 | Local therapeutic approaches – the Polish concept |
| Speaker | M. Grat, Warsaw | |
| 17:50 | 18:00 | Q&A |
| 18:00 | 19:00 | Welcome Reception |
March 8, 2025
| Start | End | Session / Presentation |
|---|---|---|
| 08:30 | 09:20 | Case Presentations by Young Oncologists Early Colorectal Cancer / Metastatic Colorectal Cancer |
| Chair | A. Sartore-Bianchi, Milan | |
| Chair | C. Zielinski, Vienna | |
| 08:30 | 08:55 | Case presentation (10 min presentation + 5 min expert comment + 10 min discussion) |
| Speaker | TBA | |
| 08:55 | 09:20 | Case presentation (10 min presentation + 5 min expert comment + 10 min discussion) |
| Speaker | TBA | |
| 09:20 | 10:10 | Novel Compounds and Strategies for the treatment of mCRC |
| Chair | R. Krasteva, Sofia | |
| 09:20 | 09:40 | Treatment of Molecularly Mutated mCRC |
| Speaker | A. Sartore-Bianchi, Milan | |
| 09:40 | 10:00 | Immunotherapy |
| Speaker | Bojidar Iliev, Sofia | |
| 10:00 | 10:10 | Q&A |
| 10:10 | 10:20 | Coffee Break |
| 10:20 | 11:00 | The importance of patient advocates |
| Chair | I. Rawicka, Otwock | |
| 10:20 | 10:40 | The importance of patient advocates |
| Speaker | I. Rawicka, Otwock | |
| 10:40 | 11:00 | Oncology coordinator in colorectal cancer patient care |
| Speaker | M. Mroczkowska, Warsaw | |
| 11:00 | 11:25 | Coffee Break |
| 11:25 | 12:05 | Interdisciplinary Discussion Defining the needs of patients with colorectal cancer and access to modern compounds: Successes and shortcomings |
| Panelist | I. Rawicka, Otwock; C. Zielinski, Vienna | |
| 12:05 | 12:15 | Coffee Break |
| 12:15 | 13:05 | Young Future Leaders Session Case presentations on the use of precision medicine in CRC presented and discussed by young oncologists Discussion by Faculty |
| Chair | R. Krasteva, Sofia | |
| Chair | C. Zielinski, Vienna | |
| 12:15 | 12:40 | Case presentation (10 min presentation + 5 min expert comment + 10 min discussion) |
| Speaker | TBA | |
| 12:40 | 13:05 | Case presentation (10 min presentation + 5 min expert comment + 10 min discussion) |
| Speaker | TBA | |
| 13:05 | 13:10 | Closing Remarks |
Please Note: That CECOG does not take any liability should a speaker cancel last minute or changes of the programme need to be made due to matters outside of CECOG’s control.
CME Accreditation
The 3rd Colon Cancer Academy, in Sofia, Bulgaria on 7-8 March 2025, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 8.0 European CME credits – 4 credits on Friday 7 March and 4 credits on Saturday 8 March, 2025 (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME®
credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal Collegeof Physicians and Surgeons of Canada.
Certificate of attendance and CME credits will be sent via email after the academy.
Registration & Accomodation Booking
The number of participants is limited to a maximum of 100 attendees.
No registration fees are charged for this meeting. One night accommodation at the meeting hotel and a refund of travel expenses up to a maximum amont of EUR 300.- will be covered by CECOG.
Registration is facilitated through an application process with the CECOG team. Our aim is to curate a diverse conference that encompasses a range of perspectives by including different specialities, geographic regions and levels of experience.
Once the application process is concluded, accepted participants will be able to book their accommodation through the CECOG website. Please note that all travel arrangements are the responsibility of the participants. We strongly advise waiting for a confirmation from CECOG before making any travel plans.
CME Accreditation
We are working on getting the 3rd Colon Cancer Academy accredited by the European Accreditation Council for Continuing Medical Education (EACCME®).
Financial Support
Do you want to be part of this exciting event? Make use of our various sponsoring options!
Contact us for more information at cecog@wma.co.at.